- Home
- AMBO vs CYCN Comparison
AMBO vs CYCN Comparison
Compare AMBO & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBO
- CYCN
- Stock Information
- Founded
- AMBO 2000
- CYCN 2018
- Country
- AMBO United States
- CYCN United States
- Employees
- AMBO N/A
- CYCN N/A
- Industry
- AMBO Other Consumer Services
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- AMBO Real Estate
- CYCN Health Care
- Exchange
- AMBO Nasdaq
- CYCN Nasdaq
- Market Cap
- AMBO 10.5M
- CYCN 8.0M
- IPO Year
- AMBO 2010
- CYCN N/A
- Fundamental
- Price
- AMBO $3.73
- CYCN $2.43
- Analyst Decision
- AMBO
- CYCN
- Analyst Count
- AMBO 0
- CYCN 0
- Target Price
- AMBO N/A
- CYCN N/A
- AVG Volume (30 Days)
- AMBO 26.9K
- CYCN 25.2K
- Earning Date
- AMBO 08-05-2025
- CYCN 11-13-2025
- Dividend Yield
- AMBO N/A
- CYCN N/A
- EPS Growth
- AMBO N/A
- CYCN N/A
- EPS
- AMBO 0.69
- CYCN N/A
- Revenue
- AMBO $9,699,000.00
- CYCN $2,174,000.00
- Revenue This Year
- AMBO N/A
- CYCN N/A
- Revenue Next Year
- AMBO N/A
- CYCN N/A
- P/E Ratio
- AMBO $5.35
- CYCN N/A
- Revenue Growth
- AMBO 23.73
- CYCN N/A
- 52 Week Low
- AMBO $1.00
- CYCN $1.27
- 52 Week High
- AMBO $5.55
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- AMBO 54.94
- CYCN 48.99
- Support Level
- AMBO $2.91
- CYCN $2.13
- Resistance Level
- AMBO $3.80
- CYCN $2.59
- Average True Range (ATR)
- AMBO 0.32
- CYCN 0.20
- MACD
- AMBO -0.19
- CYCN 0.02
- Stochastic Oscillator
- AMBO 98.18
- CYCN 55.21
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.